In the News

 

A prior authorization overhaul for Medicare Advantage beneficiaries may have a stronger chance of passage in this Congress.

• That's because of an expected lower CBO score, a new rule on the issue, and renewed urgency in a post-Chevron environment.

Why it matters: Medicare Advantage beneficiaries have faced delays and denials of care due to the prior authorization process, and health providers routinely list prior authorization issues as one of their top obstacles in doing their jobs.

A previous version of the bill passed the House unanimously by voice vote in 2022, but then stalled after the CBO issued an estimated cost of $16 billion

Click here to read the full article on Axios.